Read More Healthcare Industry News Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens Nexsen has FDA pathway momentum and Asia hospital validation. The harder test is whether ASX: NXN can turn StrepSure into revenue. bySrinathJuly 6, 2026